United Therapeutics UTHR Adcirca — Milestone payment to be made
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept uthr:MilestonePaymentToBeMadeUponCommercialLaunchOfProduct.
The official record: United Therapeutics’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's adcirca — milestone payment to be made.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is United Therapeutics's adcirca — milestone payment to be made?
- United Therapeutics (UTHR) reported adcirca — milestone payment to be made of $81.25K in Q4 2025.
- How has United Therapeutics's adcirca — milestone payment to be made changed year-over-year?
- United Therapeutics's adcirca — milestone payment to be made decreased by 0.0% year-over-year, from $81.25K to $81.25K.
- What does adcirca — milestone payment to be made mean?
- Reflects future financial obligations triggered by the achievement of specific development, regulatory, or commercial milestones for a product. These are non-recurring payments owed to partners or licensors upon reaching predefined targets.